1. Home
  2. DXR vs PNI Comparison

DXR vs PNI Comparison

Compare DXR & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daxor Corporation

DXR

Daxor Corporation

HOLD

Current Price

$12.40

Market Cap

71.4M

Sector

Health Care

ML Signal

HOLD

Logo Pimco New York Municipal Income Fund II of Beneficial Interest

PNI

Pimco New York Municipal Income Fund II of Beneficial Interest

HOLD

Current Price

$7.08

Market Cap

79.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DXR
PNI
Founded
1970
2002
Country
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
71.4M
79.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DXR
PNI
Price
$12.40
$7.08
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
7.4K
26.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
4.76%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$34.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.00
$6.03
52 Week High
$14.76
$7.89

Technical Indicators

Market Signals
Indicator
DXR
PNI
Relative Strength Index (RSI) 45.27 62.15
Support Level $12.15 $7.05
Resistance Level $12.90 $7.16
Average True Range (ATR) 0.44 0.06
MACD 0.00 0.01
Stochastic Oscillator 16.67 74.04

Price Performance

Historical Comparison
DXR
PNI

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

About PNI Pimco New York Municipal Income Fund II of Beneficial Interest

PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.

Share on Social Networks: